PTSM: Pharmaceutical Technology Sourcing and Management, Sep 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Sep 1, 2010
APIs
Exploring Chiral Chemistry
By Patricia Van Arnum
Chemocatalytic and biocatalytic approaches in asymmetric synthesis help provide a pathway for producing single-enantiomer drugs.
Outsourcing
Project Managers Wanted
By Eric Langer
Relationship management is a limiting factor to growth in biomanufacturing outsourcing.
Sourcing
DCAT Conference Focuses on Procurement/Sourcing Strategies
By Patricia Van Arnum
Procurement, sourcing, and partnerships with external suppliers take on greater importance as the pharmaceutical supply chain becomes increasingly more complex and global.
CSR and Sustainability Forum
Evaluating Global Health Progress in the Millennium Development Goals
By Patricia Van Arnum
An upcoming summit will assess the progress and gaps in realizing the UN Millennium Development Goals, including outcomes from global health initiatives.
Secretary of State Clinton Outlines US Role in Global Health
By Patricia Van Arnum
Secretary of State Hillary Clinton details the progress and future direction of the US role in the Global Health Initiative.
CSR and Sustainability Forum
A roundup of developments on corporate social responsibility from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here